News
| Feb 07 | $HRT is a verybad buy now. No more government contracts, sensor side and running some weeks only 4 days now. New side company has done nada by jjmobjj |
| Jan 25 | Wise move by $HRT to switch to a quarterly dividend rather than semi-annual. You don't get a lot of credit from LT investors for semi-annual by bradloncar |
| Jan 25 | Arrhythmia Research Technology, Inc. (HRT) Declares $0.03 Quarterly Dividend; 3.7% Yi... |
| Jan 25 | Arrhythmia Research Technology, Inc. Declares Cash Dividend Marketwire |
| Jan 09 | $HRT - Insiders only ones supporting stock to cover. CEO and BOD have to change . $36.00/share to $1.38/share. Not a good bet. by jjmobjj |
| Dec 02 | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Changes in Registrant's C... |
| Nov 14 | $HRT filed latest Quarterly Report http://stks.co/17a0 by MarketBrief |
| Nov 14 | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and... |
| Nov 14 | Arrhythmia Research Technology, Inc. Announces Third Quarter Results Marketwire |
| Nov 10 | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Financials |
| Mar 11 | Arrhythmia Research Technology ($HRT) http://stk.ly/eUMojP by frankvoisin |
Profile
Exchange: AMEX Sector: Healthcare Industry: Medical Appliances & Equipment
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Arrhythmia Research Technology is down N/A over the last year vs S&P 500 Total Return up N/A, ABIOMED up N/A, and Allied Healthcare Products down N/A.
- HRT Total Returns
- ^SPXTR Total Returns
- ABMD Total Returns
- AHPI Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these HRT related companies
Pro Strategies Featuring HRT
Did Arrhythmia Research Technology make it into our Pro Portfolio Strategies?
HRT Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other HRT Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Quote.com
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| HRT | 3.89 | 0.12 | 3.10% | 10.85M |
| RMT | 9.51 | -0.04 | -0.42% | |
| MPA | 16.60 | 0.20 | 1.22% | |
| DLN | 51.05 | -0.35 | -0.68% | |
| PHD | 13.06 | 0.04 | 0.31% | |
| JHX | 39.67 | -0.59 | -1.47% | 3.45B |
| CHW | 8.34 | -0.11 | -1.30% | |
| MBA | 0.25 | 0.00 | 0.00% | 17.78M |
| JKD | 76.36 | -0.56 | -0.73% | |
| BXG | 3.32 | 0.03 | 0.91% | 107.16M |
